GNUR 294 (GNUR 294 (GNUR294))

GNUR 294 EXAM III Nursing Application- Adrenergic Agonists • Monitor frequently of VS, urinary and cardiac output as appropriate, especially if IV used • Assess for adverse and report adverse effects: tachycardia, HTN, dysrhythmias, tremors, dysrhythmias, tremors, dizziness, headache, or decrease UO. Severe HTN, seizures or angina may signal drug toxicity report immediately • Raising the head of the bed during dyspnea will supplement therapeutic drug effects and optimize the outcome...

GNUR 294 EXAM III Pharmacotherapy of Dyslipidemia • Lipids are the culprit that help increase the levels of plaque inside the walls • Three types of lipids that the drugs are going to effect • LDL- “bad”, forms the plaque in the vessel walls • HDL- remove LDL from the bloodstream to be metabolized by the liver • Want LDL levels to be low, HDL to be high, the higher the better because the lower LDL • VLDLs- triglycerides, they are closely tied to carbohydrate metabolism...

Case Study Exam III • Probably has a lot of stress due to work because he owns his own store, higher level of stress than someone that works a regular job. Also works with wife who works in score, and might not eat the healthiest. • PMH is positive for hypertension, dyslipidemia, and a MI three years ago followed by four-vessel coronary artery bypass surgery. The patient has been asymptomatic since surgery with no complaints for chest pain o No chest pain good because he is perfusing,...

GNUR 294 EXAM IV Pharmacology of Coagulation Disorders • Affects the clotting factors- anticoagulants • Prevent platelets aggregation, doesn’t change number of platelets- antiplatelet • Breaks down clot formation- thrombolytic drugs • Anticoagulants & Antiplatelets don’t break down clots • Drugs are geared towards one of these processes • A normal response • When you damage blood vessels, and there is injury the first thing to control hemodynamics and homeostasis, t...

GNUR 294 FINAL EXAM Pharmacotherapy of Alzheimer’s Disease • Builds up these plaques and deposited between the nerve cells • When between the nerve cells cannot transmit nerve signals • Develop mainly in the area in which you learn and retain new information • Long term memory can stay intact, but the ability to learn new information is affected • The nerve fibers and cells become tangled • Begins slowly, the patient is aware that they are losing memory • We know what...

Pharmacotherapy of Infectious Diseases • Talking about bacterial infections, most prominent • Antibiotics • They don’t affect viral infections at all • They best most effective approach is prevention i.e. hand washing • Patients may allergies, pregnant, some host factors that will come into play • Antibiotic resistance- acquired, becoming a major proble clinical settings • Organisms to become resistance to the drugs • Bacteria can build up a defense i.e. MRS, VRE, MDRO...

GNUR 294 FINAL EXAM Pharmacotherapy of Non-HIV Viral Infections • Viruses differ from bacteria in the sense they are compromised of a few molecules • Intracellular parasites, present in many places, some very lethal, some can co-exist • The issue with viruses that make them so difficult is because they used the host cell, they are very difficult to kill • Anti-viral drugs are the least effective • Mutate very rapidly, resistance develops because antiviral medication is geared...

GNUR 294 FINAL EXAM Pharmacotherapy of the Endocrine System: Diabetes & Thyroid Disorders • In terms of a patient with diabetes we know that it’s a disorder of normal carbohydrate metabolism • Cells rely on glucose for ATP and energy production • Two organs that keep glucose levels within normal range • Pancreas and liver • Beta cell produces-insulin • Alpha- glucagon • Drives the glucose from the bloodstream into the cells to use and then rest goes to liver to be st...

GNUR 294 FINAL Nursing Applications Nursing Applications: Coagulation • Evaluate lab findings (aPTT, PT/INR, bleeding time), CBC, platelets, renal and liver function studies, ABGs as appropriate, lipid profiles. • Monitor vital signs and ECG every 15 mins during first hour of infusion, and then every 30 min during the remainder of the infusion. Continue to monitor vital signs 1h for the first 8h following the infusion • Monitor neurologic status frequently, especially if thrombol...

GNUR 294 Pharm Exam 4